| Product Code: ETC8565421 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Neuroimaging Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Neuroimaging Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Neuroimaging Market - Industry Life Cycle |
3.4 New Zealand Neuroimaging Market - Porter's Five Forces |
3.5 New Zealand Neuroimaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 New Zealand Neuroimaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 New Zealand Neuroimaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 New Zealand Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in New Zealand |
4.2.2 Advancements in neuroimaging technologies and techniques |
4.2.3 Growing awareness and adoption of early disease diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with neuroimaging procedures |
4.3.2 Limited availability of skilled professionals in the field of neuroimaging |
5 New Zealand Neuroimaging Market Trends |
6 New Zealand Neuroimaging Market, By Types |
6.1 New Zealand Neuroimaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Neuroimaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 New Zealand Neuroimaging Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.1.4 New Zealand Neuroimaging Market Revenues & Volume, By Computed Tomography (CT), 2021- 2031F |
6.1.5 New Zealand Neuroimaging Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.1.6 New Zealand Neuroimaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.1.7 New Zealand Neuroimaging Market Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2021- 2031F |
6.1.8 New Zealand Neuroimaging Market Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2021- 2031F |
6.1.9 New Zealand Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 New Zealand Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.2 New Zealand Neuroimaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Neuroimaging Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.3 New Zealand Neuroimaging Market Revenues & Volume, By Psychiatric Disorders, 2021- 2031F |
6.2.4 New Zealand Neuroimaging Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.3 New Zealand Neuroimaging Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Neuroimaging Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 New Zealand Neuroimaging Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 New Zealand Neuroimaging Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.5 New Zealand Neuroimaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.6 New Zealand Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
7 New Zealand Neuroimaging Market Import-Export Trade Statistics |
7.1 New Zealand Neuroimaging Market Export to Major Countries |
7.2 New Zealand Neuroimaging Market Imports from Major Countries |
8 New Zealand Neuroimaging Market Key Performance Indicators |
8.1 Average wait time for neuroimaging procedures |
8.2 Number of research collaborations between industry and academia in the neuroimaging field |
8.3 Adoption rate of new neuroimaging technologies by healthcare facilities |
9 New Zealand Neuroimaging Market - Opportunity Assessment |
9.1 New Zealand Neuroimaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 New Zealand Neuroimaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 New Zealand Neuroimaging Market Opportunity Assessment, By End User, 2021 & 2031F |
10 New Zealand Neuroimaging Market - Competitive Landscape |
10.1 New Zealand Neuroimaging Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here